SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-015086
Filing Date
2020-08-10
Accepted
2020-08-10 16:05:32
Documents
14
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36802
2 ex99-1.htm EX-99.1 77106
3 logo_001.jpg GRAPHIC 4340
  Complete submission text file 0001493152-20-015086.txt   309833

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mtnb-20200810.xsd EX-101.SCH 3210
5 XBRL LABEL FILE mtnb-20200810_lab.xml EX-101.LAB 35273
6 XBRL PRESENTATION FILE mtnb-20200810_pre.xml EX-101.PRE 23162
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3770
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 201089342
SIC: 2834 Pharmaceutical Preparations